BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260605T104224EDT-1375juGkRC@132.216.98.100
DTSTAMP:20260605T144224Z
DESCRIPTION: \n\nOn Wednesday\, February 1\, 2023\, Daniela Quail\, PhD\, A
 ssistant Professor at the Department of Physiology and Researcher at the R
 osalind and Morris Goodman Cancer Institute\, McGill University\, will be 
 giving a talk entitled “Harnessing the tumor immune microenvironment to co
 mbat disease progression” as part of the Emerging Topics of Health (EToH) 
 Seminar series\, cohosted by the Departments of Microbiology and Immunolog
 y\, Physiology and Human Genetics\, the Rosalind and Morris Goodman Cancer
  Institute\, the McGill University Research Centre on Complex Traits (MRCC
 T) and M[i]4.\n\nThere will be a 5à7 after the talk at Brass Doors Pub (21
 71 Crescent Street) and anyone (students\, postdocs\, and faculty) are wel
 come to join!\n\n \n\nGrad students and postdocs\n\nSign up to have lunch 
 with our guest speaker! If you would like to have lunch with our guest spe
 aker\, please fill out this SURVEY. The lunch will be held from 12h to 1h 
 in Room #530 in the Bellini.\n\n \n\nAbstract\n\nThe tumor immune microenv
 ironment (TIME) strongly influences disease progression\, from primary tum
 or growth to establishment of metastatic lesions. As clinical applications
  for immunotherapy are on the rise\, understanding how to harness the immu
 ne system to combat cancer at different stages of disease is gaining signi
 ficant attention in research. Many of these research efforts have been foc
 used on the adaptive immune system\, yet there is untapped translational v
 alue in leveraging innate effector functions within the myeloid compartmen
 t\, which is highly abundant within tumours. The Quail lab studies the reg
 ulatory mechanisms of myeloid maturation and recruitment into tumours\, an
 d tests the hypothesis that targeting specific myeloid states in cancer ca
 n be effective against disease progression. By utilizing highly multiplex 
 immune profiling technologies\, we are able to gain insight into the vast 
 heterogeneity of myeloid identities within tissues\, with the goal of unve
 iling new strategies to target myeloid populations and enhance immunothera
 py responses.\n
DTSTART:20230201T203000Z
DTEND:20230201T213000Z
LOCATION:Room 504\, McIntyre Medical Building\, CA\, QC\, Montreal\, H3G 1Y
 6\, 3655 promenade Sir William Osler
SUMMARY:EToH Seminar Series: 'Harnessing the tumor immune microenvironment 
 to combat disease progression'
URL:https://www.mcgill.ca/sbms/etoh-3
END:VEVENT
END:VCALENDAR